Literature DB >> 28082095

ATF3, a novel cardiac therapeutic target: Beneficial or harmful?

R Kalfon1, L Koren1, A Aronheim2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28082095     DOI： 10.1016/j.ijcard.2017.01.027

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  1 in total

1.  JDP2 and ATF3 deficiencies dampen maladaptive cardiac remodeling and preserve cardiac function.

Authors:  Roy Kalfon; Tom Friedman; Shir Eliachar; Rona Shofti; Tali Haas; Lilach Koren; Jacob D Moskovitz; Tsonwin Hai; Ami Aronheim
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.